ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,725Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 153

$695K Total Retail Price of All Prescriptions

Rank: 4 out of 153

510 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,701 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LEVOTHYROXINE SODIUM 667 580 1 1
OMEPRAZOLE 465 330 2 4
FUROSEMIDE 319 269 3 6
HYDROCODONE-ACETAMINOPHEN 272 262 S3 4 5
SIMVASTATIN 267 217 5 2
HYDROCHLOROTHIAZIDE 262 246 6 9
SERTRALINE HCL 248 225 7 16
LOSARTAN POTASSIUM 241 223 8 17
WARFARIN SODIUM 238 229 9 10
PRAVASTATIN SODIUM 236 188 10 20
METOPROLOL TARTRATE 226 213 11 11
LISINOPRIL 220 192 12 3
POLYETHYLENE GLYCOL 3350 211 100 13 41
AMLODIPINE BESYLATE 208 204 14 7
METFORMIN HCL 189 178 15 8
CITALOPRAM HBR 170 138 16 14
ALENDRONATE SODIUM 167 126 17 22
POTASSIUM CHLORIDE 159 137 18 12
ALLOPURINOL 150 114 19 25
NAMENDA 147 134 20 28
SPIRIVA 136 120 21 35
FLUTICASONE PROPIONATE 132 106 22 38
ADVAIR DISKUS 129 111 23 31
TAMSULOSIN HCL 125 106 24 24
MIRTAZAPINE 120 94 25 47
SYNTHROID 118 118 26 34
LOSARTAN-HYDROCHLOROTHIAZIDE 117 99 27 46
PREDNISONE 115 100 28 29
PANTOPRAZOLE SODIUM 108 93 29 30
BYSTOLIC 105 97 30 64
ATORVASTATIN CALCIUM 94 91 31 19
SINGULAIR 88 36 32 83
NEXIUM 85 64 33 37
CRESTOR 83 83 34 50
ZOLPIDEM TARTRATE 82 67 35 21
ESCITALOPRAM OXALATE 82 73 35 55
VENLAFAXINE HCL ER 81 55 37 70
CYMBALTA 79 55 38 39
SPIRONOLACTONE 78 76 39 48
DEXILANT 75 47 40 95
GABAPENTIN 74 61 41 15
TRAMADOL HCL 74 65 41 23
TRAZODONE HCL 73 61 43 32
BUSPIRONE HCL 72 40 44 71
METOPROLOL SUCCINATE 71 71 45 13
PREMARIN 66 53 R 46 96
ZETIA 64 37 47 133
ENALAPRIL MALEATE 61 61 48 42
AZITHROMYCIN 59 45 49 43
OLANZAPINE 58 58 50 85
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 42 51 92
CELEBREX 55 46 52 67
FLUOXETINE HCL 55 13 52 51
MELOXICAM 53 29 54 27
LEXAPRO 53 50 54 151
NIFEDIPINE ER 52 52 56 154
CEPHALEXIN 52 46 56 73
CLOPIDOGREL 50 50 58 65
EVISTA 50 25 58 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.